Clinical Trials
24
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)β’ Click on a phase to view related trials
A Comparison of VR647 and Conventionally Nebulized Budesonide in Healthy Volunteers and Adult Asthma Subjects
- Conditions
- Asthma
- First Posted Date
- 2019-07-25
- Last Posted Date
- 2019-07-25
- Lead Sponsor
- Vectura Limited
- Target Recruit Count
- 34
- Registration Number
- NCT04032834
- Locations
- πΊπΈ
Celerion, Tempe, Arizona, United States
πΊπΈAnaheim Clinical Trials, LLC, Anaheim, California, United States
A Methodology Trial Using the VR647 Inhalation System in Pediatric Subjects Who Have Previously Received Inhaled Therapy
- Conditions
- CoughWheezing
- First Posted Date
- 2019-07-08
- Last Posted Date
- 2019-07-08
- Lead Sponsor
- Vectura Limited
- Target Recruit Count
- 41
- Registration Number
- NCT04011709
- Locations
- πΊπΈ
Allergy & Asthma Associates of Southern California, Mission Viejo, California, United States
πΊπΈClinical Research Institute, Inc, Plymouth, Minnesota, United States
πΊπΈSt. Louis Children's Hospital, Saint Louis, Missouri, United States
A Study of the Pharmacokinetics, Safety and Tolerability of Single Doses of VR647 Inhalation Suspension Administered Using the VR647 Inhalation System in Children With Wheezing, Reactive Airway Disease or Mild Asthma
- Conditions
- WheezingReactive Airway DiseaseMild Asthma
- First Posted Date
- 2018-02-05
- Last Posted Date
- 2019-10-21
- Lead Sponsor
- Vectura Limited
- Target Recruit Count
- 17
- Registration Number
- NCT03421730
- Locations
- πΊπΈ
Vectura Study Site 0003, Colorado Springs, Colorado, United States
πΊπΈVectura Study Site 0002, Raleigh, North Carolina, United States
πΊπΈVectura Study Site 0001, Tulsa, Oklahoma, United States
An Evaluation of VR942 in Healthy Volunteers and Patients With Mild Asthma
- Conditions
- Asthma
- Interventions
- Drug: VR942 delivered via a Vectura Dry Powder InhalerDrug: Placebo delivered via a Vectura Dry Powder Inhaler
- First Posted Date
- 2015-06-17
- Last Posted Date
- 2016-12-21
- Lead Sponsor
- Vectura Limited
- Target Recruit Count
- 85
- Registration Number
- NCT02473939
- Locations
- π¬π§
Vectura Study Site, London, United Kingdom
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
- First Posted Date
- 2012-11-01
- Last Posted Date
- 2020-04-21
- Lead Sponsor
- Vectura Limited
- Target Recruit Count
- 197
- Registration Number
- NCT01720069
- Locations
- πΊπΈ
Vectura Clinical Trial Site 01001, Los Angeles, California, United States
πΊπΈVectura Clinial Trial Site 01005, Denver, Colorado, United States
πΊπΈVectura Clinical Trial Site 01006, Celebration, Florida, United States
- Prev
- 1
- 2
- Next